PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Clinical evidence
Leaf extracts of C. betulus exhibit remarkable antioxidant- and anticancer-related properties, suggesting potential as a medicinal raw material [PMID:36531368]
Cyclic diarylheptanoids isolated from C. betulus were evaluated for antiproliferative activity [PMID:37686297]
Evidence summary
PubMed sources
- 1.PMID: 34973466 (2022) — Isolation and quantification of diarylheptanoids from European hornbeam (Carpinus betulus L.) and HPLC-ESI-MS/MS characterization of its antioxidative phenolics. · Journal of pharmaceutical and biomedical analysis
- 2.PMID: 37686297 (2023) — Evaluation of the Chemical Stability, Membrane Permeability and Antiproliferative Activity of Cyclic Diarylheptanoids from European Hornbeam (Carpinus betulus L.). · International journal of molecular sciences
- 3.PMID: 36531368 (2022) — Responses of the growth, photosynthetic characteristics, endogenous hormones and antioxidant activity of Carpinus betulus L. seedlings to different light intensities. · Frontiers in plant science
- 4.PMID: 39502235 (2024) — Characteristics of Oak (Quercus petraea (Matt.) Liebl), hornbeam (Carpinus betulus L.) and ash (Fraxinus excelsior L.) in a plain-low hills-mountains-plateau sequence. · Heliyon